Caisson Biotech LLC, of Austin, Texas, appointed Glenn Nedwin CEO and president...Quanterix Corp., of Lexington, Mass., named Paul Chapman president and CEO...RXi Pharmaceuticals Corp., of Westborough, Mass., added Jeannette Graf and Leroy Young to its scientific advisory board

NovImmune SA, of Plan-Les-Ouates, Switzerland, added Michael Steinmetz to its board and appointed David Slack head of corporate and business development...Savient Pharmaceuticals Inc., of East Brunswick, N.J., appointed Louis Ferrari president and CEO...Xenetic Biosciences plc, of London, added Subash Kapre and Thomas Ulich to its scientific advisory board

Akshay Vaishnaw executive vice president and chief medical officer...and Thomas Rollins senior vice president of program and portfolio management

A.P. Pharma Inc., of Redwood City, Calif., added Barry Quart and Stephen Davis to it board...Saladax Biomedical Inc., of Bethlehem, Pa., named Kevin Harter president and CEO...Sequenom Inc., of San Diego, named Carolyn Beaver vice president and chief accounting officer

GenVec Inc., of Gaithersburg, Md., named Cynthia Collins president and CEO...Paratek Pharmaceuticals Inc., of Boston, appointed Dennis Molnar CEO and director and Evan Loh chief medical officer and board chairman

Generex Biotechnology Corp., of Worcester, Mass., added Keith Knutson and James Mule to its scientific advisory board...PolyTherics Ltd., of London, added Anker Lundemose and Nigel Pitchford to its board...Promedior Inc., of Malvern, Pa., appointed Suzanne Bruhn president and CEO

Tris Pharma Inc., of Monmouth Junction, N.J., named Amanda Wohlleber vice president of scale-up and technical services and Rajul Parikh vice president, operations...Vaximm AG, of Basel, Switzerland, and Mannheim, Germany, appointed Jean Paul Prieels to its board...Ziopharm Oncology Inc., of New York, appointed Jason Amello executive vice president and chief financial officer

AMAG Pharmaceuticals Inc., of Lexington, Mass., appointed William Heiden president and CEO...Blueprint Medicines, of Cambridge, Mass., named George Demetri clinical advisor and member of the scientific advisory board...Cynapsus Therapeutics Inc., of Toronto, nominated Perry Molinoff, Thomas Picone and President and CEO Anthony Giovinazzo to its board

XOMA Corp., of Berkeley, Calif., named Paul Rubin senior vice president, research and development

China Biologic Products Inc., of Beijing, added Zhijun Tong and Sandy (Han) Zhang to its board...Kolltan Pharmaceuticals Inc., of New Haven Conn., named Gerald McMahon president and CEO...Sorbent Therapeutics, of Sunnyvale, Calif., appointed Howard Dittrich chief medical officer and Randall Woods board chairman

and Santosh Varghese vice president of medical affairs...The company promoted Barbara Troupin to vice president, scientific communication and risk management...named CFO Timothy Morris senior vice president, global corporate development and finance

LLC, of Kalamozoo, Mich., added Barbara Cannon to its science and medical advisory board...Northwest Biotherapeutics, of Bethesda, Md., added Navid Malik and Jerry Jasinowski to its board...Syndax Pharmaceuticals Inc., of Waltham, Mass., appointed Arlene Morris CEO and Joanna Horobin president

Adventrx Pharmaceuticals Inc., of San Diego, formed a regulatory advisory board (RAB) and appointed Cindy Dinella and Bonnie Hepburn to the RAB, with Frank Sasinowski as RAB advisor...InDex Pharmaceuticals AB, of Stockholm, Sweden, appointed Pernilla Sandwall head of clinical operations and Thomas Knittel chief medical officer

Pluristem Therapeutics Inc., of Haifa, Israel, appointed Jeffrey Olin, Manesh Patel, Petra Reinke and J. Andre Schmidt-lucke to its new peripheral artery disease steering committee...PTC Therapeutics Inc., of South Plainfield, N.J., named Claudia Hirawat president and Mark Boulding executive vice president and chief legal officer

Constellation Pharmaceuticals Inc., of Cambridge, Mass., named Keith Dionne president and CEO and Mark Goldsmith executive chairman of the board...Intermune Inc., of Brisbane, Calif., added Jean-Jacques Bienaime and Frank Verwiel to its board...OvaScience, of Cambridge, Mass., added Jeffrey Capello and John Simon to its board

Avanir Pharmaceutics Inc., of Aliso Viejo, Calif., appointed Rohan Palekar senior vice president and chief commercial officer...ImmunoCellular Therapeutics Ltd., of Woodland Hills, Calif., appointed Richard Chin chairman of the compensation committee and added him to its board and the audit committee...Novavax Inc., of Rockville, Md., named John Hermann vice president and general counsel

CombiMatrix Corp., of Irvine, Calif., appointed Richard Ding and Joseph Limber to its board...and Christine Mikail, executive vice president, corporate development, general counsel and secretary

ImmunoGen Inc., of Waltham, Mass., added Kristine Peterson and Dean Mitchell to its board...and added Eunan Maguire senior vice president of strategy and corporate development

ImmunoGen Inc., of Waltham, Mass., added Kristine Peterson and Dean Mitchell to its board...and added Eunan Maguire senior vice president of strategy and corporate development